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Introduction / objectives
Bacterial resistance to antimicrobials has increased over
the years, but the importance of empirical investigation of
these bacteria contributes to the prevention of spread
within the institution. The Infection Control Comission
Protocol has as surveillance for resistant organisms since
1996.In Brazil, Klebsiela pneumoniae carbapenemase
enzyme (KPC) was the first described in 2005 with an
increased number of cases in the last year, prompting us
to seek the epidemiological profile of inpatients.
Methods
Observational study in a general hospital for investigation
of asymptomatic KPC, in two periods with an interval of
three months between October 2010 and February 2011,
with population as inpatients in the Intensive Care Unit
and Medical Clinics with time hospitalization exceeding
20 days or Precaution Contact by resistant microorgan-
isms, which were held in four anal swab samples.
Results
We selected a total of 108 patients, 20 of these (18%) were
excluded from the study, 13 (12%) were discharged from
hospital, 5 (5%) died, 2 (2%) were transferred to another
hospital. A total of 128 samples were included, where
seven (5.4%) tested positive for KPC and 4 (4.5%) patients
were colonized.
Conclusion
Actions surveillance to identify resistant organisms, imple-
mentation of precaution-based transmission mode, adopt-
ing the policy of hand hygiene using alcohol gel at the
point of care, allow for the prevention of spread among
patients with risk factors such as prolonged hospitaliza-
tion, immunosuppression and the use of many antibiotics.
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